key: cord-0794083-fli9q23x
authors: AZ Khan, Mohammed; Mahmood, Tahir; Konje, Justin C
title: Covid-19 and its implications for the provision of gynecological services globally
date: 2022-02-26
journal: Eur J Obstet Gynecol Reprod Biol
DOI: 10.1016/j.ejogrb.2022.02.176
sha: 34d5111468439ca4942adce11c16278e87df110c
doc_id: 794083
cord_uid: fli9q23x

Covid-19 took the world by surprise and has completely changed the way humans live and work. There is hardly an aspect of life that has not been affected. Whether social, economic, physical, psychological, cultural or religious, this pandemic has revolutionized every aspect of our lives and some of these changes are here to stay for the unforeseeable time. Although much has been written about the negative effects of Covid-19 on our social lives, some technological advances on COVID-19 have profoundly affected various aspects of our lives. These are mostly to do with how we communicate, deliver health services, innovate and investigate new preventative measures and treatments, travel and indeed influenced the carbon footprint of the planet. Although most of gynaecology is elective and was therefore not considered a priority in the early phases of COVI-19, there are considerable consequences of delaying treatment for some of these elective conditions. Of particular importance are infertility, pre-malignant conditions, chronic pelvic pain, sexual disorders and those affecting the psychological and social aspects of women and families. The pandemic forced a rethink of how healthcare is delivered with wide adoption of remote/virtual consultation and triaging of clinical presentations. The rapid development of immunization and drugs against the virus was met with doubts by a large proportion of the population with reluctance to accept these. Consequently, there remains unvaccinated portions of both low and high-risk populations, some of whom may be denied access to gynaecological care. On the other hand, some pregnant women who are frightened of the impact of vaccination on pregnancy put their own lives at risk. While significant progress has been made to combat the pandemic, lessons about healthcare delivery (face-to-face versus virtual), education of the end users and introduction of new technologies into the development of drugs and vaccines must be evaluated and improved moving forward not only during the ongoing epidemic but with future outbreaks.

Corona viruses have generally been the cause of various infections in mammals, birds and humans, where they specifically target the respiratory system. Over the past 20 years, there have been three new corona virus related lethal outbreaks of zoonotic origin. 

SARS CoV-2 is characterized by a comparatively higher basic reproductive number (Ro) which further explains its rapid spread worldwide (8) . It belongs to the ortho-coronavirinae subfamily and is the seventh member of the family of Corona viruses that infects humans.

The virus is spherical with a core shell and surface with protein projections like the spikes of a crown, hence named Corona (Crown in Latin). The most important of the three main proteins is the spike (S) protein which is responsible for attachment to the host cell membrane receptor followed by fusion and finally entry into the host cell. The remaining two are the membrane (M) protein which is the most abundant and the envelope (E) protein and together they make the viral membrane. Another, the N protein is part of the helical nucleocapsid that includes the genome RNA (9).

The virus has a single-stranded positive-sense RNA of around 30 kb and is nonsegmented (10) . Phylogenetic analysis of the virus shows that SARS CoV-2 shares more than 80% genetic sequences with SARS-CoV-1 and more than 50% with MERS (11) . The WHO has classified the virus as β CoV of the group 2B (12) (13) .

Epidemiological evidence suggests that SARS-CoV-2 is zoonotic in origin with bats being the primary host and spreading to humans via an intermediary host, probably pangolin, which is eaten in China as an exotic food (14) . The widespread nature of the disease worldwide suggests rapid person-to-person transmission, probably through different routes but mainly via direct contact and droplet spread through coughing and sneezing by infected individuals (15) .

SARS-CoV-2 causes the disease that has been named COVID-19 by the WHO. With an incubation period of approximately 5.2 days (2 -14 days), the clinical manifestations are widespread ranging from no symptoms to acute severe respiratory distress syndrome (ARDS) and multiple organ failures. Covid-19 also shares some clinical features with other beta corona viruses such as dry cough, high grade fever and pneumonia with bilateral ground glass opacities on Chest CT (16) . Just like MERS-CoV and SARS-CoV-1 infections, a comparatively greater proportion of Covid-19 patients may also develop gastro-intestinal symptoms such as diarrhoea . SARS-CoV-2 uniquely targets the lower airways (17) where it causes destruction of pneumocytes with infiltrating inflammation (18) . Other clinical features include loss of smell and taste. The development of acute respiratory distress syndrome (ARDS), cardiac and lung injury are poor prognostic features that could ultimately lead to death (19) .

The gold standard for detecting SARS CoV-2 is reverse transcription polymerase chain reaction (RT-PCR) from the respiratory tract or salivary secretions. Other methods for the detection of SARS-CoV-2 include viral identification and immunological tests (20a).

Laboratory findings supporting the diagnosis include a combination of lymphopenia, high levels of hs-CRP (high sensitivity C-reactive protein) and eosinopenia; all of which are useful in triaging patients highly suspicious of SARS-CoV-2 infection and requiring radiological/CT evaluation of the chest for evidence of pneumonia. Other tests like blood gases, troponin levels, liver function tests, lactate dehydrogenase (LDH) and D-dimers are used to assess the risk and extent of multi-system involvement and prognosis.

Procalcitonin levels are used to detect possible bacterial coinfection (20b).

The mainstay of treatment is supportive as there is as yet no definitive treatment for Covid-19. Symptomatic treatment focuses mainly on rest, hydration, temperature control and nutritional support. Oxygen therapy is needed if the patient fails to maintain adequate oxygen levels which may necessitate mechanical ventilation. The use of corticosteroids such as dexamethasone and anticoagulation with low molecular weight heparin have been shown to reduce mortality in those that are severely ill (21, 22) .

SARS-CoV-2, due to its extreme infectivity and virulence, has had a major impact on healthcare systems across the globe regardless of the socio-economic status of the countries. This has seriously challenged the integrity and resilience of these systems (23) (24) . Its impact on global socioeconomic dynamics has been so severe that many of the world's otherwise stable economies and indeed all the other economies are still struggling to sustain their health services (25) (26) . However, Covid-19 has demonstrated how collectively the world can willingly collaborate in research and share knowledge and technical know-how to address such health challenges. The case of vaccine development over such a short time is a classical example of this global co-ordination. The speed with which some of these developments have moved, however, has attracted severe criticism for not following the basic principles of research methodology and thus possibly compromising the quality of research with the potential of misleading results (27) . Indeed, various studies published data of efficacy of drugs such as hydroxychloroquine on the virus that were later shown to be unsubstantiated (28) .

The available evidence suggests that, although individuals of all ages are affected, the case fatality is age dependent with elderly men suffering the most especially those with comorbidities (29) . Interestingly, there is now compelling evidence that females are less severely affected by Covid-19 disease compared to males who suffer higher morbidity and mortality (30) . These differences were also observed with other viral epidemics including SARS-CoV-1 and MERS (31) . Whether this is because of the risk prone life style of males with comparatively more co-morbidities or some other perhaps biological factors, which make females less vulnerable to these infections remains uncertain.

SARS-CoV-2 uses its spike protein (S) to attach to the ACE 2 receptor on the alveolar epithelial membrane. It needs the Transmembrane protease serine 2 (TMPRSS2) to act as a vital factor priming the S protein which it cleaves thus facilitating activation and entry into the host cell. (32) (33) .

Interestingly, it has been suggested that the two X chromosomes in females as opposed to one in males are associated with the highest number of immune regulated genes in the whole human genome (34) . Normally one of the two X chromosomes in females is transcriptionally silenced as per the Lyon theory (35) . Interestingly, about 15-30% of the genes, mostly located on the short arm of the X-chromosome escape the silencing process (36) . Since ACE2 maps at the same location on the short arm of X-chromosome which escapes inactivation, the observed difference and more ACE2 expression in females could be due to this phenomenon (37) . More ACE2 availability in females means more availability for converting angiotensin-I into Angiotensin 1-7 (Ang 1-7) which promotes tissue protection via the Mas receptor (MasR) (38) . Theoretically, more ACE2 in females would mean more viral entry into cells but the rate limiting crucial factor TMPRSS2 expression is thought to be lower in females due to low androgens and high estrogens thus providing another level of protection (38) .

Additionally, difference in hormone profiles with females being estrogenic and males are androgenic, has been suggested to lead to a better immune-modulation (driven by estrogens) in females, making them less vulnerable to viral attacks (39) . In fact, there is evidence supporting the anti-viral role of estrogens against a group of viruses including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), Ebola virus (EBV),

Social distancing 2 meters (2M) between individuals) imposed by most authorities as a preventive measure and widely accepted to reduce the spread of SARS-CoV-2. This was based on old data (44) which did not take into consideration, other factors such as hand hygiene and cleaning, air management, use of personal protective equipment (PPEs) including face masks involved in respiratory transmissions of these viruses (45) (46) .

The pandemic drove the need for innovative/alternate approaches to delivery of healthcare. Amongst these initiatives was virtual consultation. Face-to-face consultations in hospitals have therefore decreased significantly especially for minor complaints, in favor of virtual consultations since the onset of the pandemic. In Scotland for example all new and review appointments were quickly re-categorized to assess their suitability for virtual consultation for initial assessment and treatment advice. More than 50% patients can and are being managed through this arrangement. The Royal College of Obstetricians & Gynaecologists (RCOG) guidance about the initial management of patients in these circumstances has been implemented within the UK NHS system (47).

Unpublished data from Scotland has also shown a significant fall in the number of women requesting termination of pregnancy. Covid-19 related changes in health service modelling has also led to >80% of women being managed at home using medical regimens as recommended by the RCOG (47).

Gynecological emergency services in some French hospitals witnessed a 41% drop in face-to-face consultations and comparatively a smaller (20%) drop in emergency admissions with a significant increase in the hospitalization to consultation ratio (3.9 % to 5.4%; P< 0.0001), during the Covid-19 peaks (48) . It is not clear if the drop was due to patients' reluctance to attend for fear of acquiring the virus especially if their condition was not judged to be severe or due to diversion of available resources when the whole focus was on controlling the spread and providing critical care to those affected by Covid- 19 . In another study conducted in a tertiary academic center in New York, a significant increase (P< 0.001) in the proportion of gynecological emergency surgical procedures (for ectopic pregnancy, miscarriage and concern for cancer) was noticed during the Covid -19 time (49) .

With respect to the emergency care of ectopic pregnancies, it seems Covid -19 was associated with higher rate of rupture with higher morbidity reported in a tertiary medical facility in Tel Aviv (50) . Whether similar trends were noticed for other gynecological emergencies is yet to be reported.

Reproductive health includes a harmonized state of social, psychological, mental and physical health that is so necessary for procreation in a healthy environment.

Reproductive health has been affected not only by SARS-CoV-2 itself but by the pharmacological /chemical interventions given to those exposed to the virus and the impact of the pandemic on provision of services (often not considered as emergency).

On entering the body SARS-CoV-2 binds to the angiotensin converting enzyme 2 (ACE-2) receptor through its spike (S) protein (43) . This interaction is mediated, by the transmembrane protease serine 2 (TMPRSS2) or cathepsins B and L (encoded by the genes CTSB and CTSL respectively), when TMRSS2 is absent (51) . Evidence remains inconclusive on whether the female genital tract is one of the prime targets of SARS-CoV-2 due to the sparse presence of ACE-2 and TMRSS2 receptors (52) . Human ovaries, on the other hand, have been shown to express ACE-2 receptor activity in relation to folliculogenesis and maturation, steroid synthesis and ovulation, hence are a potential target for SARS-CoV-2 which may potentially cause damage via the ACE2 /TMPRSS pathway (53) (54) .

In males, there is robust evidence of ACE-2 receptors and TMPRSS2 expression on testicular tissue suggesting a potential damage by SARS-CoV-2 to this organ and potentially an adverse effect on its function (55) (56) . Additionally, testosterone seems to facilitate SARS-CoV-2 spread via activation of TMPRSS2 (57) thus increasing the attractiveness of the virus onto the testicular tissue. Although orchitis is a recognized complication of the SARS-CoV group (58) , it is believed that SARS-CoV-2 through binding to ACE2 receptor, may potentially cause orchitis and possible testicular atrophy and sub-fertility (59) . Furthermore, there have been reports of isolation of SARS-CoV-2 in semen of infected males (60) raising the possibility of sexual transmission.

For pregnant women affected with Covid-19, emerging data do not show any robust evidence of vertical transmission, however, SARS-Cov-2 may increase the risk of miscarriage and is associated with a significantly higher risk of preterm birth but not stillbirths (53) (54) .

Obstetrics and Gynecology professional bodies across the globe including the WHO, 

Sub-fertility or infertility affects 8-12% of couples trying to conceive and has significant adverse physical, mental and social consequences if not treated timely. However, during Covid-19 pandemic, it was not considered requiring urgent care. However, it is a time sensitive condition whose prognosis gets worse with time. Provision of services for this condition were therefore suspended at the start of the pandemic as recommended by the With regard to staffing, it was recommended that shifts and duties be scheduled for critical staff members so as to avoid exposure to SARs-CoV-2 of all of them together. This was supported by adequate contingency plans to combat acute staff shortage. On the whole, these recommendations seem to endorse those from other international societies including ESHRE, ASRM and the IFFS as mentioned above (66) .

With regards to the requirement for covid-19 testing, ESHRE endorsed selective testing unlike the British fertility society (BFS) and the association of reproductive and clinical scientists (ARCS) who recommended testing at the start of treatment and prior to any procedure (68) . The later more cautious approach also catered for the almost 18 -30% asymptomatic carriers who could be contagious despite being asymptomatic (69) .

Vaccination is seen as the best way to reduce the spread of the pandemic as well as its consequences. The available vaccines are either inactivated SARS-CoV-2 vaccine, RNA Vaccines or non-replicating vector vaccine (70) . The WHO maintains a working document that includes the various vaccines that are in different phases of development (71) .

Results of phases I, II and III trials on most of these support their clinical efficacy (72) .

While phase III trials were on various populations, none were on women in early pregnancy or indeed undergoing fertility treatment. The impact/effect of the vaccines on gametes and early embryos is therefore unknown. In a joint statement (73) In the context of reproduction, a recent study of men who had been vaccinated did not show any adverse effects of the mRNA vaccine on sperm parameters. There seems to be an improvement on parameters in oligozoospermic men (74). In women, the vaccine was shown to have no effect on response to ovulation stimulation as well as parameters of successful stimulation (75-76). In animals, the vaccine has been shown to have no adverse effects on reproduction (77). The decision to have vaccination finally rests with the woman and the role of her physician is to guide her through the decision making by answering queries and providing facts.

One of the serious emerging phenomena in the post Covid-19 era is the risk of re-infection and even more seriously, infection after vaccination rarely leading to serious morbidity or death. Various factors have been suggested for these phenomena namely inefficiency of natural immunity, variants of major epitopes in cases of re-infections (82) (83) (84) and possibly high viral load, co-morbidities, mutant strains, casual attitudes with lack of Covidappropriate behavior before and after vaccination in cases of infection after vaccination (85) .

While Covid-19 has caused severe morbidity and mortality world-wide, including having a major impact on cancer surgery with considerable delays that inevitably will affect survival data, it has allowed for the introduction of innovative/new ways to current and future healthcare as well as potential avenues for training and research in medicine.

Some of these innovations/new approaches to healthcare include 1-increased use of telemedicine not only in triaging but management of nonemergency cases, 2-Increased role of medical methods of managing gynaecological problems in preference to surgical interventions (for example heavy menstrual bleeding (HMB) with more reliance on the levonorgestrel intra-uterine system, oral progestogens, gonadotropin releasing hormone-agonist (GnRHa,) endometrial ablations under local block) etc.

3-Greater investment on simulation training for undergraduate and postgraduate training as advocated by the EBCOG in its position statement (86) 4-Increased utilization of alternatives to care as in the case of termination of pregnancy which has been revised so as to allow women to take mifepristone (RU 486) at home. Unpublished data after 12 months in Scotland showed that only 5% of admissions with bleeding following this approach required emergency evacuation.

Covid-19 has had devastating effects not only on the physical, mental and social aspects of human health but also on the economy which indirectly affects health across the globe.

Women's health in general and reproductive health in particular suffered significantly from the pandemic. This pandemic brought together international societies and the WHO to address the health challenges -resulting in guidance on care, prevention and treatment -a collaboration which if replicated could have a major impact on other health challenges.

Postponing elective work, minimizing face-to-face consultations in favor of virtual consultations, prioritizing and individualizing care based on needs and the available resources without compromising safety. At the outset most of gynaecology apart from emergency and oncology were not considered priority. As understanding of the epidemiology of the epidemic improved, aspects that could be managed virtually were defined and with time, reproductive medicine resumed albeit with clear guidance. With a gradual return to near normal, the backlog of patients (such as on the NHS Waiting list) will continue to negatively affect those seeking gynaecological care (including reproductive medical services). There is a need to continue to undertake efficacy and safety trials of treatment and prevention options while at the same time gathering data on vaccination and reproductive and pregnancy outcomes and on the innovative approaches to healthcare which are likely to persist.

Covid-19 took the world by surprise and has completely changed the way humans live and work. There is hardly an aspect of life that has not been affected. Whether social, economic, physical, psychological, cultural or religious, this pandemic has revolutionized every aspect of our lives and some of these changes are here to stay for the 

Coronavirus disease 2019-COVID-19

Characteristics of SARS-CoV-2 and COVID-19

A timeline of the coronavirus. The New York Times

World Health Organization. WHO Director-General's Opening Remarks at the Media Briefing on COVID-19-11 March2020

World Health Organization. WHO Corona virus (Covid-19) Dashboard

COVID-19, SARS and MERS: are they closely related

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

World Health Organization, World Health Organization. WHO MERS global summary and assessment of risk

The molecular biology of coronaviruses

Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host & microbe

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases

A novel coronavirus from patients with pneumonia in China

COVID-19: epidemiology, evolution, and cross-disciplinary perspectives

Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet

A major outbreak of severe acute respiratory syndrome in Hong Kong

A major outbreak of severe acute respiratory syndrome in Hong Kong

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet

Severe SARS-CoV-2 infection in critical care

Dexamethasone in hospitalized patients with Covid-19

Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study

COVID-19 pandemic: A multifaceted challenge for science and healthcare. Trends in Anaesthesia & Critical Care

Swedish policy analysis for Covid-19. Health Policy and Technology

Examining the Economic and Environmental Impacts of COVID-19 Using Earth Observation Data. Remote Sensing

Global Economic Effects of COVID-19

The carnage of substandard research during the COVID-19 pandemic: a call for quality

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and metaanalysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet

Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome

Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. The Lancet Infectious Diseases

Race to find COVID-19 treatments accelerates

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell

The X chromosome and immune associated genes

Gene action in the X-chromosome of the mouse (Mus musculus L.). nature

Escape from X-chromosome inactivation: an evolutionary perspective. Frontiers in cell and developmental biology

Landscape of X chromosome inactivation across human tissues

Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome

Could Estrogen Protect Women From COVID-19?

Estrogen protects against vaginal transmission of simian immunodeficiency virus. The Journal of infectious diseases

17β-estradiol protects females against influenza by recruiting neutrophils and increasing virusspecific CD8 T cell responses in the lungs

17beta-estradiol inhibits the production of infectious particles of hepatitis C virus

Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection. PloS one

Uber luftinfection

Two metres or one: what is the evidence for physical distancing in covid-19?. bmj

When You Are Sick, to prevent the spread of COVID-19 Stay home except to get medical care. When You Are Sick, do not share personal

Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care

Where Have All the Emergencies Gone? The impact of the COVID-19 pandemic on obstetric and gynecologic procedures and consults at a New York City hospital

Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis. The Lancet Regional Health-Europe

SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. The EMBO journal

Female reproductive tract has low concentration of SARS-CoV2 receptors. Plos one

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its effect on gametogenesis and early pregnancy

Coronavirus disease 2019 (COVID-19) pandemic and pregnancy

scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia

SARS-CoV-2 presence in seminal fluid: Myth or reality

Testosterone, a key hormone in the context of COVID-19 pandemic

Orchitis: a complication of severe acute respiratory syndrome (SARS)

Impact of COVID-19 and other viruses on reproductive health

Clinical characteristics and results of semen tests among men with coronavirus disease 2019

A guide to WHO's guidance on COVID-19

COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics | ACOG

Has COVID-19 subverted global health? Lancet

COVID-19 FAQs for obstetrician-gynecologists, Gynecology. COVID-19 FAQs

Royal College of Obstetricians and Gynecologists. Corona virus (Covid-19) and gynaecological services

International Federation of Gynecology and Obstetrics. Covid-19 (Corona virus) statement. FIGO.2020

Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE and IFFS. Hum Reprod Open

COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine

COVID-19 screening during fertility treatment: how do guidelines compare against each other?

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

A systematic review of SARS-CoV-2 vaccine candidates. Signal transduction and targeted therapy

Draft landscape of COVID-19 candidate vaccines. World Health Organisation

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vaccines

Joint IFFS/ESHRE statement on COVID-19 vaccination for pregnant women and those considering pregnancy

Sperm Parameters Before and After COVID-19 mRNA Vaccination

Ravit Nahum and Adva Aizer Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?

Klement Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination

Claudia Lindemann Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine

COVID-19 vaccination in pregnant and lactating women

for the CDC v-safe COVID-19 Pregnancy Registry Team Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination

EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women

Co-infection, re-infection and genetic evolution of SARS-CoV-2: Implications for the COVID-19 pandemic control

Elucidating reasons of COVID-19 reinfection and its management strategies

COVID-19 re-infection

Elucidating causes of COVID-19 infection and related deaths after vaccination